If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry

Pouwels, X. G. L., Ramaekers, B. L. T., Geurts, S. M. E., Erdkamp, F., Vriens, B. E. P. J., Aaldering, K. N. A., van de Wouw, A. J., Dercksen, M. W., Smilde, T. J., Peters, N. A. J. B., van Riel, J. M. G. H., Pepels, M. J., Heijnen-Mommers, J., Tjan-Heijnen, V. C. G., de Boer, M. & Joore, M. A., 16 Jun 2020, In : Acta Oncologica. 59, 9, p. 1123-1130 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study

van Nijnatten, T. J. A., Simons, J. M., Smidt, M. L., van der Pol, C. C., van Diest, P. J., Jager, A., van Klaveren, D., Kam, B. L. R., Lobbes, M. B. I., de Boer, M., Verhoef, K., Koppert, L. B. & Luiten, E. J. T., Aug 2017, In : Clinical Breast Cancer. 17, 5, p. 399-402 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10 years of follow up

Brouwers, P. J. A. M., van Loon, J., Houben, R. M. A., Paulissen, J., Engelen, S. M. E., Heuts, M., de Boer, M., Verhoeven, K., De Ruysscher, D. & Boersma, L. J., 1 Jan 2018, In : Radiotherapy and Oncology. 126, 1, p. 163-169 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study

van Hellemond, I. E. G., Smorenburg, C. H., Peer, P. G. M., Swinkels, A. C. P., Seynaeve, C. M., van der Sangen, M. J. C., Kroep, J. R., de Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., van den Berkmortel, F. W. P. J., de Boer, M., de Roos, W. K., Linn, S. C., Imholz, A. L. T., Tjan-Heijnen, V. C. G. & Dutch Breast Canc Res Grp BOOG, 1 Sep 2019, In : International Journal of Cancer. 145, 5, p. 1325-1333 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies

Vriens, B. E. P. J., Keymeulen, K. B. M. I., Kroep, J. R., Charehbili, A., Peer, P. G., de Boer, M., Aarts, M. J. B., Heuts, E. M., Tjan-Heijnen, V. C. G. & Dutch Breast Canc Res Grp BOOG, 11 Jul 2017, In : Oncotarget. 8, 28, p. 46557-46564 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial

Dutch Breast Canc Res Grp BOOG, Apr 2020, In : Breast Cancer Research and Treatment. 180, 3, p. 675-685 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium

Seferina, S. C., de Boer, M., Derksen, M. W., van den Berkmortel, F., van Kampen, R. J. W., van de Wouw, A. J., Joore, M., Peer, P. G. M., Voogd, A. C. & Tjan-Heijnen, V. C. G., May 2016, In : Oncologist. 21, 5, p. 555-562 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium

Seferina, S. C., Ramaekers, B. L. T., de Boer, M., Dercksen, M. W., van den Berkmortel, F., van Kampen, R. J. W., de Wouw, A. J. V., Voogd, A. C., Heijnen, V. C. G. T. & Joore, M. A., 3 Oct 2017, In : Oncotarget. 8, 45, p. 79223-79233 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Diagnostic challenges of respiratory adverse events during everolimus treatment

Willemsen, A. E. C. A. B., De Vos, F. Y., Jansen, A., de Boer, M., Tjan-Heijnen, V. C. G. & van Herpen, C. M. L., Sep 2014, In : Targeted Oncology. 9, 3, p. 287-291

Research output: Contribution to journalArticleAcademicpeer-review

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer

Vriens, B. E. P. J., Aarts, M. J. B., de Vries, B., van Gastel, S. M., Wals, J., Smilde, T. J., van Warmerdam, L. J. C., de Boer, M., van Spronsen, D. J., Borm, G. F. & Tjan-Heijnen, V. C. G., Oct 2013, In : European Journal of Cancer. 49, 15, p. 3102-3110

Research output: Contribution to journalArticleAcademicpeer-review

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure

van Hellemond, I. E. G., Vriens, I. J. H., Peer, P. G. M., Swinkels, A. C. P., Smorenburg, C. H., Seynaeve, C. M., van der Sangen, M. J. C., Kroep, J. R., de Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., van den Berkmortel, F. W. P., de Boer, M., de Roos, W. K., Linn, S. C., Imholz, A. L. T., Tjan-Heijnen, V. C. G. & Dutch Breast Canc Res Grp BOOG, 1 Jul 2019, In : International Journal of Cancer. 145, 1, p. 274-283 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane

Willemsen, A. E. C. A. B., de Geus-Oei, L-F., de Boer, M., Tol, J., Kamm, Y., de Jong, P. C., Jonker, M. A., Vos, A. H., Grootjans, W., de Groot, J. W. B., Mulder, S. F., Aarntzen, E. H. J. G., Gerritsen, W. R., van Herpen, C. M. L. & van Erp, N. P., Oct 2018, In : Targeted Oncology. 13, 5, p. 641-648 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Tjan-Heijnen, V. C. G., van Hellemond, I. E. G., Peer, P. G. M., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., De Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., van den Berkmortel, F. W. P. J., de Boer, M., de Roos, W. K., Linn, S. C., Imholz, A. L. T., Seynaeve, C. M. & Dutch Breast Canc Res Grp B, Nov 2017, In : Lancet oncology. 18, 11, p. 1502-1511 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Fachal, L., Aschard, H., Beesley, J., Barnes, D. R., Allen, J., Kar, S., Pooley, K. A., Dennis, J., Michailidou, K., Turman, C., Soucy, P., Lemacon, A., Lush, M., Tyrer, J. P., Ghoussaini, M., Marjaneh, M. M., Jiang, X., Agata, S., Aittomaki, K., Rosario Alonso, M. & 36 others, Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arason, A., Arndt, V., Aronson, K. J., Arun, B. K., Auber, B., Auer, P. L., Azzollini, J., Balmana, J., Barkardottir, R. B., Barrowdale, D., Beeghly-Fadiel, A., Benitez, J., Bermisheva, M., Bialkowska, K., Blanco, A. M., Blomqvist, C., Blot, W., Bogdanova, N., Bojesen, S. E., Bolla, M. K., Bonanni, B., Borg, A., Bosse, K., Brauch, H., Brenner, H., de Boer, M., Garcia, E. G., Blok, M., GEMO Study Collaborators, EMBRACE Collaborators, KConFab Investigators, HEBON Investigators & ABCTB Investigators, Jan 2020, In : Nature Genetics. 52, 1, p. 56–73 25 p.

Research output: Contribution to journalArticleAcademicpeer-review

Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort study

van Abbema, D., van Vuuren, A., van den Berkmortel, F., van den Akker, M., Deckx, L., Buntinx, F., van Kampen, R., Lambooij, E., de Boer, M., de Vos-Geelen, J. & Tjan-Heijnen, V. C., May 2017, In : Journal of Geriatric Oncology. 8, 3, p. 176-184 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

Vriens, B. E. P. J., Vriens, I. J. H., Aarts, M. J. B., van Gastel, S. M., van den Berkmortel, F. W. P. J., Smilde, T. J., van Warmerdam, L. J. C., van Spronsen, D. J., Peer, P. G. M., de Boer, M., Tjan-Heijnen, V. C. G. & Breast Canc Trialists Grp, Oct 2017, In : Breast Cancer Research and Treatment. 165, 3, p. 593-600 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

Lobbezoo, D. J. A., van Kampen, R. J. W., Voogd, A. C., Dercksen, M. W., van den Berkmortel, F., Smilde, T. J., van de Wouw, A. J., Peters, F. P. J., van Riel, J. M. G. H., Peters, N. A. J. B., de Boer, M., Peer, P. G. M. & Tjan-Heijnen, V. C. G., Feb 2016, In : Annals of Oncology. 27, 2, p. 256-262 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis

Aarts, M. J., Vriens, B. E., de Boer, M., Peters, F. P., Mandigers, C. M., Dercksen, M. W., Stouthard, J. M., Tol, J., van Warmerdam, L. J., de Wouw, A. J. V., Jacobs, E. M., van der Rij, C. C. D., Smilde, T. J., van der Velden, A. W., Peer, N. & Tjan-Heijnen, V. C. G., 2017, In : Oncology. 93, 5, p. 323-328 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure

van Hellemond, I. E. G., Vriens, I. J. H., Peer, P. G. M., Swinkels, A. C. P., Smorenburg, C. H., Seynaeve, C. M., van der Sangen, M. J. C., Kroep, J. R., de Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., van den Berkmortel, F. W. P. J., Kitzen, J. J. E. M., de Boer, M., de Roos, W. K., Linn, S. C., Imholz, A. L. T., Tjan-Heijnen, V. C. G. & Dutch Breast Canc Res Grp BOOG, Dec 2017, In : Journal of the National Cancer Institute. 109, 12, 9 p., 074.

Research output: Contribution to journalArticleAcademicpeer-review

Pleidooi voor selectief gebruik van de MammaPrint

de Boer, M., Voogd, A. & Tjan - Heijnen, V., 11 Apr 2017, In : Nederlands Tijdschrift voor Geneeskunde. 161, 3 p., D1160.

Research output: Contribution to journalArticleAcademicpeer-review

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

Vriens, I. J. H., ter Welle-Butalid, E. M., de Boer, M., de Die-Smulders, C. E. M., Derhaag, J. G., Geurts, S. M. E., van Hellemone, I. E. G., Luiten, E. J. T., Dercksen, M. W., Lemaire, B. M. D., van Haaren, E. R. M., Vriens, B. E. P. J., van de Wouw, A. J., van Rie, A. M. G. H., Janssen-Engelen, S. L. E., van de Poel, M. H. W., Schepers-van der Sterren, E. E. M., van Golde, R. J. T. & Tjan-Heijnen, V. C. G., May 2020, In : Breast Cancer Research and Treatment. 181, 1, p. 77-86 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

Lobbezoo, D. J. A., van Kampen, R. J. W., Voogd, A. C., Dercksen, M. W., van den Berkmortel, F., Smilde, T. J., van de Wouw, A. J., Peters, F. P. J., van Riel, J. M. G. H., Peters, N. A. J. B., de Boer, M., Borm, G. F. & Tjan-Heijnen, V. C. G., Oct 2013, In : Breast Cancer Research and Treatment. 141, 3, p. 507-514

Research output: Contribution to journalArticleAcademicpeer-review

Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location

Vestjens, J. H., de Boer, M., van Diest, P. J., van Deurzen, C. H., van Dijck, J. A., Borm, G. F., Adang, E. M., Bult, P. & Tjan-Heijnen, V. C., Jan 2012, In : Breast Cancer Research and Treatment. 131, 2, p. 645-651

Research output: Contribution to journalArticleAcademicpeer-review

Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane

Willemsen, A. E. C. A. B., Tol, J., van Erp, N. P., Jonker, M. A., de Boer, M., Meek, B., de Jong, P. C., van Moorsel, C., Gerritsen, W. R., Grutters, J. C. & van Herpen, C. M. L., Aug 2019, In : Targeted Oncology. 14, 4, p. 441-451 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium

van Kampen, R. J. W., Ramaekers, B. L. T., Lobbezoo, D. J. A., de Boer, M., Dercksen, M. W., van den Berkmortel, F., Smilde, T. J., van de Wouw, A. J., Peters, F. P. J., van Riel, J. M. G., Peters, N. A. J. B., Tjan-Heijnen, V. C. G. & Joore, M. A., Jul 2017, In : European Journal of Cancer. 79, p. 238-246 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Regional Recurrence in Breast Cancer Patients With Sentinel Node Micrometastases and Isolated Tumor Cells

Pepels, M. J., de Boer, M., Bult, P., van Dijck, J. A., van Deurzen, C. H., Menke-Pluymers, M. B., van Diest, P. J., Borm, G. F. & Tjan-Heijnen, V. C. G., Jan 2012, In : Annals of Surgery. 255, 1, p. 116-121

Research output: Contribution to journalArticleAcademicpeer-review

Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study

van Roozendaal, L. M., Smit, L. H. M., Duijsens, G. H. N. M., de Vries, B., Siesling, S., Lobbes, M. B. I., de Boer, M., de Wilt, J. H. W. & Smidt, M. L., Apr 2016, In : Breast Cancer Research and Treatment. 156, 3, p. 465-472 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Symptom burden and its association with change in glucose metabolism status over a 7-year period: the Hoorn Study

van der Pols-Vijlbrief, R., Dekker, J. M., Stehouwer, C. D., de Boer, M. R., Nijpels, G., Snoek, F. J. & Adriaanse, M. C., Jun 2014, In : Diabetic Medicine. 31, 6, p. 747-753

Research output: Contribution to journalArticleAcademicpeer-review

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients

Vriens, I. J. H., De Bie, A. J. R., Aarts, M. J. B., de Boer, M., van Hellemond, I. E. G., Roijen, J. H. E., van Golde, R. J. T., Voogd, A. C. & Tjan-Heijnen, V. C. G., 14 Feb 2017, In : Oncotarget. 8, 7, p. 11372-11379 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer

Vriens, B., de Vries, B., Lobbes, M. B. I., van Gastel, S. M., van den Berkmortel, F. W. P. J., Smilde, T. J., van Warmerdam, L. J. C., de Boer, M., van Spronsen, D. J., Smidt, M. L., Peer, P. G. M., Aarts - Essers, M. & Tjan-Heijnen, V. C. G., Jan 2016, In : European Journal of Cancer. 52, p. 67-76 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands

Schneider, P. P., Pouwels, X. G. L. V., Passos, V. L., Ramaekers, B. L. T., Geurts, S. M. E., Ibragimova, K. I. E., de Boer, M., Erdkamp, F., Vriens, B. E. P. J., van de Wouw, A. J., den Boer, M. O., Pepels, M. J., Tjan-Heijnen, V. C. G. & Joore, M. A., 9 Apr 2020, In : PLOS ONE. 15, 4, 14 p., 0230909.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access